Purpose Acute angle-closure glaucoma is a common ophthalmic emergency and individuals with shallow anterior chambers and suspected narrow angles are increasingly referred to the hospital eye service for assessment. There appears to be variation in subsequent management, with no national consensus or college guidelines. This study ascertains the current use of prophylactic YAG iridotomy in patients with no known history of an acute angle-closure glaucoma attack, and also the methods used in patient selection. 
Introduction
Ophthalmologists in the UK are increasingly required to appropriately manage individuals with shallow anterior chambers and suspected narrow angles but no symptoms or past ophthalmic history, who have been referred to the hospital eye service by their optometrist for assessment and consideration for prophylactic Nd:YAG laser peripheral iridotomy (YPI).
The prevalence of glaucoma varies with age and ethnic origin and for middle-aged Caucasians is reported to be 2.1-3.0% for the open-angle form and 0.3% for angle-closure. 1, 2 Worldwide, however, angle-closure glaucoma is the leading cause of blindness. 3 Narrow angles are an anatomical trait, which predispose to two potential sight-threatening conditions; firstly, an acute angle-closure episode, which presents relatively commonly in the Western world as an ophthalmic emergency, and secondly, a more chronic angle-closure glaucoma (PACG) more common among Oriental and Eskimo populations. 3 A previous series has demonstrated the characteristics of eyes that develop angle-closure; namely shallow anterior chambers, narrow angles, small corneal diameter, small corneal radius of curvature, short axial length, thick lens, and relative anterior displacement of the lens. 4 There is variation in the estimated prevalence of narrow or 'occludable' angles across the globe, quoted as 2.2-5.0% in Caucasian subjects over 55 years of age, rising markedly to 47.8% in similarly aged Vietnamese subjects. [5] [6] [7] The annual incidence of acute angle-closure glaucoma (AACG) is estimated at 3.8 per 100 000 in unselected European populations. 8 Wilensky et al followed a cohort of 129 predominantly Caucasian individuals with narrow angles or anterior chamber depth less than 2 mm and no symptoms for a mean of 2.7 years. Eight patients (6.2%) developed an acute angle-closure attack with symptoms during the follow-up period and an additional 17 patients (13.2%) were found to have angles closed with synechiae or by apposition on follow-up gonioscopy. 9 Recently, Thomas et al have shown, in an Asian cohort, that 22% of primary angle closure suspects developed raised intraocular pressure (IOP) or synechiae over a 5-year period 10 and in a separate smaller group with known primary angle closure 28.5% progressed to glaucoma as evidenced by disc damage and perimetry defects over the same period. 11 Despite these studies, there is still paucity of larger studies with long-term data on the natural history of treated and untreated narrow angles, particularly among Caucasian populations.
An AACG episode is associated with significant morbidity but a relatively safe, simple and noninvasive prophylactic procedure in the form of YPI is available. Complications of this technique are uncommon and usually transient, but include bleeding from the iridotomy site, acutely raised IOP, anterior uveitis, posterior synechiae formation, acceleration of cataract development, and corneal decompensation. 12 Additionally, subjective monocular blurring or a bluish hue have been reported 13 and are thought to be related to suboptimal siting of the YPI.
In the 1950s, Lowe 4 documented higher rates of acute angle-closure attacks in the untreated fellow eyes of patients with previous AACG and now few clinicians would deny such a patient an iridotomy in the fellow eye. The situation is less clear in those who present incidentally with shallow anterior chambers or narrow angles and while prompting recent debate 14 there remains no general consensus on the role of YPI in asymptomatic (no pain, redness, or visual symptoms such as blurring or haloes, and no documented history of AACG) individuals with potential for occlusion. Anecdotal evidence suggests that clinical practice varies widely within units, locally and nationally. This study was therefore conducted to determine the preferences and current practice patterns of UK consultant ophthalmologists in an attempt to assist all ophthalmologists in their decision to proceed to iridotomy or not.
Methods

A five-point questionnaire was mailed in May 2003
to all UK ophthalmologists appearing on our database of 650, together with an explanatory letter. It asked 'do you perform YAG iridotomy for shallow anterior chambers and/or narrow angles prophylactically in patients with no known history of an acute angle-closure episode?' It then asked if patient symptoms, IOP, gonioscopy, and provocative tests were employed in patient selection. Respondents were required to circle a yes/no option for each question, to provide further information on any provocative tests used and finally whether glaucoma was the respondents' subspecialty/area of interest. Data were collated anonymously and analysed.
Results
In all, 546 consultant ophthalmologists returned their questionnaire (84% response rate), 543 correctly completed and three incomplete. A total of 135 respondents (25.3%) indicated they never perform prophylactic YPI and 14 (10.4%) of this group quoted glaucoma as their subspecialty or area of interest.
A total of 408 consultant ophthalmologists (74.7%) confirmed they perform prophylactic YPI. Of these, 347 (85.0%) take into account patient symptoms/history and 268 (65.6%) presenting IOP. In all, 394 (96.6%) confirmed gonioscopy is essential in patient selection, and within this group 234 expressed a preference for Goldmann only, 120 for Zeiss 4 mirror only and 40 for consecutive use of both techniques. Nine (2.2%) reported that they routinely attempt formal manual measurement of AC depth (Table 1) . 
Discussion
This survey reveals that the majority of consultant ophthalmologists in the UK (74.7%) do perform prophylactic YPI in eyes with narrow angles but no history of an AACG attack and, with a response rate of 84%, it may be accepted as broadly representative.
The aim of YPI is to spare the patient from the potentially devastating symptoms and visual morbidity associated with an acute angle-closure attack. Two recent prospective studies 15, 16 confirm YPI to be as effective as surgical iridectomy in the treatment of fellow eyes, YPI being noninvasive and therefore the preferred mode of prophylaxis. Some may regard the above as overtreatment citing inappropriate utilisation of resources, theoretical YAG laser risks as listed above, an absence of long-term followup data, and a slight residual risk of angle-closure and elevation of IOP even in the presence of a patent iridotomy.
Four respondents appeared to suggest that they perform YPI on the basis of patient symptoms or history alone. Nine reported they routinely attempt formal measurement of anterior chamber depth/angle width during slit-lamp examination, all preferring Van Herrick's method 17 in which limbal anterior chamber depth is expressed as a fraction of corneal thickness. None reported any attempt at objective measurement of axial anterior chamber depth, for example, A-scan ultrasound.
With regard to provocative tests, 18 instillation of drops is common practice compared to the dark room prone test and personal preference appears to be exercised in choosing the type and strength of pharmacological agent. The majority of 'drop users' use tropicamide only, some use a combination of pilocarpine and phenylephrine, previously described as the Mapstone test, 19 and a minority cyclopentolate. All re-check subsequent IOP with a rise of 4-10 mmHg generally being deemed significant. A few additionally use pilocarpine, stating they look for an IOP fall of 48 mmHg as an indication for proceeding to YPI. Notably, among respondents specialising in glaucoma, extremes of practice were identified ranging from gonioscopy only to a repertoire including indentation gonioscopy, dark room/prone test, and then mydriatics.
Additionally, there is a group who did not use elective provocative tests but who will perform prophylactic YPI if, after routine mydriasis, the patient complains of symptoms or an elevation in IOP is documented. Provocative tests have been used for over 30 years in the UK but the dark room prone test is not in contemporary use. Possible reasons include pressures on clinic time, patient limitations such as frailty or poor mobility, clinician apathy, and a shift in organisational culture with an increasingly low threshold to proceed to YPI. Certainly, previous authors have questioned the value of such tests, suggesting that they have no increased predictive value than a slit-lamp examination combined with gonioscopy. 9, 20, 21 The potential for occludability under natural circumstances is only one factor in deciding whether to proceed to YPI. Many respondents advocated YPI in eyes requiring repeated mydriasis for diagnosis or treatment of, for example, diabetic retinopathy and the Rotterdam study 5 estimates the incidence of AACG under such circumstances at 3.8 per 10 000 while another study, also in a Caucasian population, suggests up to 15% of AACG cases could be considered as drug induced. 8 Several respondents also indicated a lower threshold for YPI in patients with pigment dispersion syndrome and those who regularly travel to countries with limited specialist healthcare.
Miscellaneous comments regarding alternative anglewidening options included a preference for lens extraction and implant if significant cataract is present, 22 surgical iridectomy over YAG laser iridotomy, diode laser iridoplasty, and simple clinic follow-up. The use of topical pilocarpine to decrease the likelihood of AACG did not appear to be current common practice, and it should not be relied upon for prevention or treatment. Several respondents who stated they never perform prophylactic YPI did however state that they would refer such patients to colleagues specialising in anterior segment/glaucoma for a final opinion.
In view of the lack of widely accepted and published definitions of angle-closure glaucoma and a degree of subjectivity in assessing the narrow angle, our questionnaire was kept necessarily simple. The exact wording and content of the questions (as detailed in methods) may have led to certain interpretations that inevitably had an impact on respondents' answers and, in turn, the results of the survey. Distinct entities exist under the umbrella of 'narrow' or 'angle-closure glaucomas' and terms in the literature are often inconsistent, arbitrary, and evolving, such that accurate comparison of data across studies becomes difficult. 23 Foster et al 24 have recently highlighted deficiencies in the epidemiological definition of the narrow or occludable angle and the implications in an east Asian population and a practical definition for readers is any eye in which 1801 (possibly 2701) or more of the angle is not visible on gonioscopy. Correctly speaking, primary angle-closure glaucoma (PACG) requires the presence of optic disc change and/or a reproducible defect on perimetry, while a narrow angle with raised IOP but no optic disc damage should be termed angle-closure glaucoma suspect.
Ophthalmologists in Europe and the USA are familiar with the dramatic acute form of angle-closure of which individuals with narrow angles have an increased but not absolute risk. Our study relates to the prophylactic use of YPI in this group with the aim of preventing pupil block, an acute rise in IOP and associated visual morbidity. As previously stated, the prevalence of occludable angles in Caucasians is 2.2-5.0% but only a small proportion will go on to develop raised IOP and optic neuropathy, that is true PACG that has a prevalence of 0.09-0.17%. While these numbers may seem low, it should be remembered that the optometry service is particularly well established in the UK and there is a culture among the majority of the population to attend a routine eye test. Taking the UK population as 80 million and the above prevalence rates, even with conservative projections, thousands of individuals in the UK may eventually reach the hospital eye service for consideration for YPI.
In summary, this novel study presents the current practice of the majority of UK consultant ophthalmologists with 74.7% performing YPI as prophylaxis against AACG in patients who have narrow/occludable angles but have not sustained an acute attack in either eye. The most popular regime applied in patient selection for YPI is a combination of symptoms, presenting IOP and Goldmann indirect gonioscopy. Our survey yields new data in a clinical area where there is a deficient evidence base and will hopefully encourage further discussion in the UK to firstly adopt a precise and practical definition of the occludable angle and also to clarify the role and limitations of prophylactic YPI.
